TY - JOUR
T1 - PER2 controls lipid metabolism by direct regulation of PPARγ
AU - Grimaldi, Benedetto
AU - Bellet, Marina Maria
AU - Katada, Sayako
AU - Astarita, Giuseppe
AU - Hirayama, Jun
AU - Amin, Rajesh H.
AU - Granneman, James G.
AU - Piomelli, Daniele
AU - Leff, Todd
AU - Sassone-Corsi, Paolo
N1 - Funding Information:
We thank C.C. Lee, B. Spiegelman, M.A. Lazar, E. Borrelli, M. Argentini, M.S. Sharpley, and all members of the Sassone-Corsi lab for reagents and discussions. B.G., M.M.B., and S.K. are supported by postdoctoral fellowships from Allergan, Inc., Associazione Italiana per la Ricerca sul Cancro (AIRC), and the Japan Society for the Promotion of Science, respectively. This work was supported by grants from the National Institute of Health (R01-GM081634-01 and R21 AG033888) to P.S.-C.
PY - 2010/11/3
Y1 - 2010/11/3
N2 - Accumulating evidence highlights intriguing interplays between circadian and metabolic pathways. We show that PER2 directly and specifically represses PPARγ, a nuclear receptor critical in adipogenesis, insulin sensitivity, and inflammatory response. PER2-deficient mice display altered lipid metabolism with drastic reduction of total triacylglycerol and nonesterified fatty acids. PER2 exerts its inhibitory function by blocking PPARγ recruitment to target promoters and thereby transcriptional activation. Whole-genome microarray profiling demonstrates that PER2 dictates the specificity of PPARγ transcriptional activity. Indeed, lack of PER2 results in enhanced adipocyte differentiation of cultured fibroblasts. PER2 targets S112 in PPARγ, a residue whose mutation has been associated with altered lipid metabolism. Lipidomic profiling demonstrates that PER2 is necessary for normal lipid metabolism in white adipocyte tissue. Our findings support a scenario in which PER2 controls the proadipogenic activity of PPARγ by operating as its natural modulator, thereby revealing potential avenues of pharmacological and therapeutic intervention.
AB - Accumulating evidence highlights intriguing interplays between circadian and metabolic pathways. We show that PER2 directly and specifically represses PPARγ, a nuclear receptor critical in adipogenesis, insulin sensitivity, and inflammatory response. PER2-deficient mice display altered lipid metabolism with drastic reduction of total triacylglycerol and nonesterified fatty acids. PER2 exerts its inhibitory function by blocking PPARγ recruitment to target promoters and thereby transcriptional activation. Whole-genome microarray profiling demonstrates that PER2 dictates the specificity of PPARγ transcriptional activity. Indeed, lack of PER2 results in enhanced adipocyte differentiation of cultured fibroblasts. PER2 targets S112 in PPARγ, a residue whose mutation has been associated with altered lipid metabolism. Lipidomic profiling demonstrates that PER2 is necessary for normal lipid metabolism in white adipocyte tissue. Our findings support a scenario in which PER2 controls the proadipogenic activity of PPARγ by operating as its natural modulator, thereby revealing potential avenues of pharmacological and therapeutic intervention.
UR - http://www.scopus.com/inward/record.url?scp=78049437320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049437320&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2010.10.005
DO - 10.1016/j.cmet.2010.10.005
M3 - Article
C2 - 21035761
AN - SCOPUS:78049437320
SN - 1550-4131
VL - 12
SP - 509
EP - 520
JO - Cell Metabolism
JF - Cell Metabolism
IS - 5
ER -